[Analysis of clinical experience in the use of metronidazole as a radiosensitizer of tumors].
D001932:Brain Neoplasms / Q000532:radiotherapy; D002986:Clinical Trials as Topic; D004938:Esophageal Neoplasms / Q000532:radiotherapy; D005260:Female; D005833:Genital Neoplasms, Female / Q000532:radiotherapy; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D007822:Laryngeal Neoplasms / Q000532:radiotherapy; D008175:Lung Neoplasms / Q000532:radiotherapy; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage*; D009369:Neoplasms / Q000532:radiotherapy*; D012516:Osteosarcoma / Q000532:radiotherapy; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage*; D012004:Rectal Neoplasms / Q000532:radiotherapy; D013274:Stomach Neoplasms / Q000532:radiotherapy; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy
D011838:Radiation-Sensitizing Agents; D008795:Metronidazole
Analiz klinicheskogo opyta primeneniia metronidazola v kachestve radiosensibilizatora opukholeĭ.